Toward a multimodal neuroprotective treatment of stroke

Stroke; a Journal of Cerebral Circulation
Andreas RogalewskiWolf-Rüdiger Schäbitz

Abstract

Stroke remains a common medical problem with importance attributable to the demographic changes in industrialized societies. After years of setbacks, acute stroke therapy has finally emerged, including thrombolysis with tissue plasminogen activator (t-PA). However, t-PA treatment is limited by a narrow time window and side effects, so that only 3% of all stroke patients receive thrombolysis. Unimodal targeting of key events in stroke pathophysiology was not effective in providing long-term benefits, leading to negative results in previous clinical neuroprotective stroke trials. A successful future stroke therapy should approach multiple pathophysiological mechanisms besides revascularization at once, including reduction of t-PA-related side effects, prevention of cell death, stimulation of neuroregeneration, and plasticity. Strategies targeting these processes include multiple combination therapies as well as treatment with multimodal drugs that interact with these mechanisms. Here, we review such combination approaches, and outline how this concept could be developed into future stroke treatment.

References

Mar 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·K WelteM A Moore
Dec 14, 1995·The New England Journal of Medicine·UNKNOWN National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
Jul 1, 1995·Journal of Neurosurgical Anesthesiology·W L Lanier
Oct 1, 1993·Neurological Research·K OvergaardG Boysen
Aug 1, 1995·Progress in Neurobiology·H Katsuki, S Okuda
Jun 1, 1996·Journal of the Neurological Sciences·W R SchäbitzM Fisher
May 1, 1997·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·W R SchäbitzW Hacke
Feb 23, 1999·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·B SpinnewynP E Chabrier
Aug 11, 1999·Trends in Neurosciences·U DirnaglM A Moskowitz
Oct 20, 2001·Cerebrovascular Diseases·J Grotta, UNKNOWN Combination Therapy Stroke Trial Investigators
Nov 14, 2001·Neurology·W M ClarkUNKNOWN Citicoline Stroke Study Group
Feb 22, 2002·The New England Journal of Medicine·UNKNOWN Hypothermia after Cardiac Arrest Study Group
Jun 22, 2002·Annals of the New York Academy of Sciences·Y WangJ Hoffer
Oct 31, 2002·Cerebrovascular Diseases·Julien BogousslavskyUNKNOWN European-Australian Fiblast (Trafermin) in Acute Stroke Group
Dec 7, 2002·Stroke; a Journal of Cerebral Circulation·Antoni DávalosRafael Lozano
Mar 8, 2003·Stroke; a Journal of Cerebral Circulation·W-R SchäbitzS Schwab
Apr 12, 2003·Stroke; a Journal of Cerebral Circulation·Jaroslaw AronowskiJames C Grotta
Apr 12, 2003·Stroke; a Journal of Cerebral Circulation·Paisith PiriyawatJames C Grotta
Jul 11, 2003·Annals of the New York Academy of Sciences·Midori A YenariGary K Steinberg
Jan 17, 2004·Stroke; a Journal of Cerebral Circulation·Heng ZhaoGary K Steinberg
Jan 23, 2004·Experimental Neurology·Christian BergerStefan Schwab
Apr 3, 2004·Stroke; a Journal of Cerebral Circulation·Carsten CulmseeJosef Krieglstein

❮ Previous
Next ❯

Citations

Jan 25, 2008·Der Nervenarzt·A Rogalewski, W-R Schäbitz
Jul 27, 2012·European Radiology·Marilena MarinescuMarlène Wiart
Oct 19, 2006·Acta Neuropathologica·Martin HasselblattWolf-Rüdiger Schäbitz
Aug 25, 2011·Nature Reviews. Nephrology·Cristina KarohlPaolo Raggi
Feb 24, 2009·Journal of Neurotrauma·Thomas M Hemmen, Patrick D Lyden
Feb 17, 2009·Journal of Neurotrauma·Xian N TangMidori A Yenari
Apr 30, 2010·Rejuvenation Research·Svetlana V UkraintsevaAnatoli I Yashin
Aug 19, 2010·Pharmacological Reviews·Stephen F TraynelisRay Dingledine
Dec 10, 2008·Stroke; a Journal of Cerebral Circulation·Thomas M Hemmen, Patrick D Lyden
Dec 20, 2012·Stroke; a Journal of Cerebral Circulation·Ok-Nam BaeArshad Majid
Mar 3, 2009·Expert Opinion on Emerging Drugs·Kenneth M Sicard, Marc Fisher
Jun 1, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Irja Elliott DonaghueMolly S Shoichet
Apr 26, 2012·Frontiers in Neuroendocrinology·Daniela GiulianiSalvatore Guarini
Aug 24, 2010·Medical Hypotheses·Kiyoshi KikuchiMinoru Shigemori
Jul 1, 2009·Neurochemistry International·Parto S Khansari, Robert F Halliwell
Oct 28, 2010·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Victoria E O'CollinsDavid W Howells
Jun 16, 2011·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Cameron RinkChandan K Sen
Apr 26, 2007·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Wolf-Rüdiger SchäbitzArmin Schneider
Feb 2, 2012·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Victoria E O'CollinsDavid W Howells
Jul 30, 2015·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Thorsten R DoeppnerDirk M Hermann
Jun 26, 2007·European Journal of Pharmacology·Daniela GiulianiSalvatore Guarini
Jun 10, 2015·Experimental Neurology·Ziping HanXunming Ji
Aug 31, 2007·Journal of Neurochemistry·Alan R YoungDenis Vivien
Jul 10, 2007·Biotechnology Journal·Serge Timsit, Bénédicte Menn
Apr 5, 2016·International Journal of Molecular Sciences·Yoon-Kyum Shin, Sung-Rae Cho
Aug 1, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Anup TuladharMolly S Shoichet
Aug 13, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yuanfei WangMolly S Shoichet
Feb 5, 2015·The New England Journal of Medicine·Jeffrey L SaverUNKNOWN FAST-MAG Investigators and Coordinators
May 18, 2016·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Dmitriy N AtochinMark B Plotnikov
Nov 9, 2016·Medical Gas Research·Li-Jun LiangXin-Chun Jin
Aug 16, 2016·Anesthesiology Clinics·Rafi Avitsian, Sandra B Machado
Mar 1, 2008·Stroke; a Journal of Cerebral Circulation·Sean I Savitz, Wolf-Rüdiger Schäbitz
Jan 31, 2007·Stroke; a Journal of Cerebral Circulation·Thomas M Hemmen, Patrick D Lyden
Oct 16, 2010·Stroke; a Journal of Cerebral Circulation·Wolf R SchäbitzArmin Schneider
Nov 14, 2015·Stroke; a Journal of Cerebral Circulation·Dafin F MuresanuAlla Guekht
Nov 24, 2006·Stroke; a Journal of Cerebral Circulation·Marlène WiartYves Berthezène
Jan 14, 2017·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Tatsuya FukutaNaoto Oku
Jun 26, 2020·Expert Review of Neurotherapeutics·Bruno P MeloniNeville W Knuckey

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.